Transplantation immunity is the state of heightened resistance to a tissue graft which develops after an earlier graft has been broken down. Techniques for the detection of transplantation immunity have been developed by Medawar (1, 2) for skin, and by Mitchison (3, 4) for transplantable tumors. Ceils from the lymphoid tissue of immunized mice have been shown to possess the power of transferring immunity, by Brncic, Hoecker, and Gasic (5) and Mitchison (3, 4) with transplantable tumors, and by Biningham, Brent, and Medawar (6) with skin homografts. Evidence has been presented by Billingham, Brent, and Medawar that the immunologically activated tissue of the donor continues to function in the host after transfer; for immunity acquired in this way they have coined the term "adoptive immunity."
applicable to grafts of normal tissue. The evidence is now very strong that transplantation immunity is not different in principle from other types of immlmity, and that it shows particular resemblance to sensitization of the delayed reaction type (1, 2, 7, 8) . The present study of transfer of transplantation immunity may therefore be regarded as an extension of the studies which have been made of transfer of cells engaged in the production of antibodies against bacterial antigens, and of cellular transfer of sensitivity ((9-11); references to earlier work are given by Billingham, Brent, and Medawar, (5)).
TABLE I

Inbred Strains and Tumors
Strain
Allele at histocompatibility-2 locus Tumor * As determined by Snell, Smith, and Gabrlelson (12) . Allele H-g" was formerly referred to as H-g ~, and produces the antigens H-g '~ and H-g k.
~t Hereafter referred to as SAI. § As determined by Dr. G. D. Snell (data unpublished). II As determined by Snell and Borges (15) .
Materials and Methods
Inbred Strains and Turaors.--The tumors and strains of mice used in this work are shown in Table I . The histocompatibility-2 (1t-2) locus of the mouse is a locus determining susceptibility and resistance to tumor (and presumably also normal tissue) transplants, i.e. a locus controlling isoantigens. Information about this locus has been used extensively in the design of the present experiments.
Strains A, BALB/C, C57BL/10, C57BL/6Ks, C57BR/a, C57L, C3H, DBA/2, and LP are standard inbred strains (13) . Strains C57BL/10, C57BL/6Ks, and C57L are dosdy related to one another. Tumors originating in C$?BL/10 normally also take in C57BL/6, and ~¢e ~ersa, but C57BL/OKs is a variant substrain carrying the H-2 ~ allele, and so is resistant to other C57BL tumors. C57BL tumors of recent origin do not take in C57L, indicating that although both strains have the same H-2 gene, differences must exist at other hlstocompatibility loci.
Strains, A.SW, BI0.D2, BID.LP, C.BO, D2.W, and LP.RIII are "isogenic resistant lines," developed by Dr. G. D. Snell by back-crossing a histocompatibility gene onto the genetic background of an inbred strain (14) . The portion of their designation preceding the dot indicates the strain with which they are effectively isogenlc, except at one histocompatibiUty locus. All these lines had been passed through at least 6 back-crosses (Ii generations of crossing) at the time of their use. Strain C57BL/IO-H-2 d derives from a mutation in the C57BL/10 strain, and is thought to be isogenic with this strain except at the H-2 locus (15). C57BL/10-H-2 ~ and BI0.D2 therefore have apparently identical genetic constitutions; nevertheless the BII tumor which originated in C57BL/10--H-2 d and which takes unlformly in this strain was found not to grow in BI0.D2 hosts. Residual differences must therefore exist between these two strains, even though both are H-2 ~ and both are thought to be isogenic with C57BL/10 except at this locus.
All the mice were bred in the colony of Dr. G. D. SneLl, except for strain C57BL/10-H-2 d which was bred in the colony of Dr. P. R. F. Borges, and strain C57BL/OKs which was bred in the colony of Dr. N. Kaliss. The tumors used are maintained as routine in the Roscoe B. Jackson Memorial Laboratory by subcutaneous transplantation, and transplants were made available for this work as needed.
Tumors were ordinarily transplanted by trocar subcutaneously into the right flank. For certain purposes Sarcoma 1 (SAI) tissue was forced through a coarse grid, taken up in a syringe, and injected through a 19 gauge needle subcutaneously into the tall, following the procedure of Andervont (16) . SAI was also converted into, and maintained as, an ascites tumor, so that counted numbers of cells could be injected subcutaneously into non-susceptible mice as a test of immunity. The ascites tumor was maintained in A hosts by intraperitoneal transfer of approximately 3 X 106 cells at intervals of 7, 8, or 9 days. For subcutaneous injection, ascitic fluid was withdrawn from the peritoneum, diluted with an equal volume of isotonic sodium citrate, and counted in a standard hemocytometer. An appropriate dilution was then made up by the addition of isotonic citrate.
Lym/~h Node and S~leen T, ansfer.--For tmnder of regional lymph node ceils after subcutaneous implantation of tumor in the flank, the sx.illary, brachlal, and inguinal nodes from the side of implantation were taken. The nodes were trimmed free of fat and were bathed in Ringer solution. The Ringer solution used for bathing lymph nodes and for suspending lymph node cells contained 1 ml. of McIlvalne's buffer (pH 7.2) and 1 nil. of stock glucose solution (600 mg./ml.) for every 100 ml. of medium (17) . Nodes were occasionally found overgrown by tumor, and were then not transferred. Some, and occasionally all, of the regional lymph nodes showed marked hypertrophy after a foreign tumor had been growing for a few days, and greatly enlarged lymphatic ducts could frequently be seen. For transfer of normal lymph node cells, the axiflary, brachial, inguinal, and two superficial cervical nodes were taken from both sides of each donor. The weight of this tissue is nearly equal to the weight, per donor, of the lymph nodes draining a 9 day old tumor homograft.
Lymph node cells were transferred as a tissue mince, by collecting sufficient nodes for transfer into a single host and chopping them finely with scissors. A little Ringer solution was then drawn up into a 0.25 mi. syringe with the nozzle bored out to a diameter of 1 ram., and the mince drawn up and injected through a 19 gauge needle into the peritoneum of the host. Lymph node cells were also transferred as a suspension; pooled minced nodes was transferred onto a metal seive (holes 0.0055 X 0.0055 inch, as used by Snell (17)), and washed through with Ringer solution, allowing 1 mi. fluid for each 6 nodes. The resulting suspension consisted largely of single ceils, and appeared in Giemsa-stained sections to comprise more than 95 per cent of lymphocytes. The cells were counted in a hemocytometer, and appropriate quantities injected intraperitoneally.
The same procedure was used for the transfer of spleen as for minced lymph nodes. Lymph nodes were regularly transferred at a dosage of 4 donors per host, and were well tolerated. With the equivalent weight of spleen, a dosage of 1 donor per host, the hosts often looked sickly, and a mortality as high as 3 deaths in 28 animals occurred in one experiment.
EXPERIMENTAL
The Survival Time of Tumor Homografts
Accurate information on the time of breakdown of homografts provides a scale against which the immunological reactions of the host can be measured. The timing also provides a means of distinguishing immunized from nonimmunized animals, for grafts in immunized hosts are broken down more rapidly (4, 6) . The survival time of SA1 in normal C57BR/a hosts and of C1498 in normal B10.D2 hosts was therefore measured, following the procedure described in an earlier paper (4) . The survival time of SA1 was also measured in C57BR/a hosts immunized by a graft of the tumor given 30 days before the test implantation. Single grafts of tumor were implanted by trocar; after various intervals they were excised, and a portion reinjected into the strain of origin of the tumor, to test their viability. Growth of the tumor on reinjection indicated survival of the test graft in the non-susceptible host. The proportions of grafts viable are shown in Table II These survival times also show that the conditions of a tumor homograft at 8 days is an adequate measure of the degree of immunization of the host, and this criterion was accordingly adopted in subsequent experiments.
The Duration of the Power of the Regional Lymph Nodes to Confer Immunity
The ability of lymph nodes draining a regressing tumor to confer immunity against the tumor was tested according to the experimental design employed by Mitchison (4) and by Billingham, Brent, and Medawar (6) . In order to measure the time of origin and the duration of this power to confer immunity, groups of regional nodes were transferred, at intervals after implantation of the graft immunizing the donor. Measurements were made after implanting SA1 into C57BR/a hosts, and also 6C3HED into C57BL/10 hosts. They were also made after reinjecting SA1 into previously immunized C57BR/a hosts, the second grafts being given 3 to 8 weeks after the first, and in the same area.
The donors of the lymph nodes were implanted with tumor by trocar. After the appropriate interval, the prospective donors were bled immediately before the nodes were taken, so that the ability of their blood to confer passive immunity could be tested. Bleeding was by cardiac puncture into isotonic sodium citrate, the blood from each group of donors being pooled. A volume equivalent to 0.5 ml. whole blood was injected intraperituneally into each of a group of mice of the same strain as the donors. A second injection of the same amount was given 1 day later from a portion of the pool stored at 4°C. A second group of mice of the same strain as the donors received the lymph nodes draining the immunizing graft, transferred as mince at a dosage of 4 donors per host. A third group received the axillary, brachial, and inguinal nodes from the side of the donors opposite the immunizing graft, transferred in the same way and at the same dosage. A fourth group consisted of untreated mice of the same strain, and a fifth of mice actively immunized by graft of tumor given at least 10 days earlier. All five groups were injected within a few hours after receiving the lymph node cells with a test graft of tumor in the flank. 8 days later these grafts were excised and a portion implanted subcutaneously into the strain susceptible to the tumor, to test their viability. The viability of the test grafts is shown in Table HI . The test grafts in the untreated control hosts showed a high viability, and in the actively immunized controls a low viability, as expected. In no case did the viability in the groups The viability of test grafts in certain groups of hosts of transferred regional nodes was lower than in the untreated controls: in these groups there is therefore evidence of transfer of immunity. The conclusion can be drawn, that in C57BR/a hosts after a first graft of SA1, and also in C5?BL/10 hosts after a first graft of 6C3HED, the regional lymph nodes confer real immunity during a period which began between 3 and 5 days, and ended between 10 and 15 days, after tumor implantation. In C57BR/a hosts the power to confer immunity was revived between 0 and 2 days, and declined between 7 and 10 days after a resthnulating injection of SA1, although the power of the regional lymph nodes to confer immunity during this secondary response was not so complete as after the initial immunization. At the doses transferred, the contmlateral nodes showed no power to confer immunity. Nor did the blood, either while the lymph nodes were active or later while serum antibody might have been expected to increase. The weights of the regional lymph nodes, reported in the succeeding paper (19) , show by comparison with these results that the nodes can confer immunity only while they are markedly hypertrophied. The contralateral nodes showed slight hypertrophy, and their failure to confer immunity may therefore have been the result of transfer of insufficient cells. Tests of the power of the spleen to confer immunity also gave negative results, with the spleen taken 10 or 15 days after the immunizing graft of tumor and transferred at a dosage of one spleen per host. Since Billingham, Brent, and Medawar (6) have reported weak transfer of immunity with spleen, this failure may also have been due to transfer of insufficient cells.
The data for SA1 in C57BR/a hosts from Tables II and H I are combined in fig. 1 . It can be seen that the regional lymph nodes were active in conferring immunity during and immediately before the time of graft breakdown. During the secondary response a relation was evident between the more rapid activation of the regional lymph nodes and the earlier breakdown of the graft.
Enhancing of Tumor Growth by Serum from Immunized Mice
No inhibition of tumor growth was found in the secondary hosts receiving blood from immunized donors in the previous experiment, and in fact the test grafts appeared to grow more rapidly in these mice than in the controls. Enhanced growth of tumor cells treated with isoimmune serum has indeed been mentioned by Gofer (20), and serum from mice treated with lyophilized tissue has been reported to enhance the growth of tumor homografts by Kaliss, Molorout, Harriss, and Gault (21) . A more pronounced enhancement of tumor growth was brought about by transfer of a larger quantity of serum, in the following experiment:--A group of C57BR/a mice were injected with SA1 by trocar, and bled after 15 days, at a time when the titre of hemaggintinating antibody in their serum was at a maximum (22) . A pool of serum was prepared and stored at -20°C. Six C57BR/a mice were injected with SA1 by trocar, followed by 9 intraperitone'al injections of 0.5 ml. of the serum, given at intervals of 2 days commencing on the day of implantation. Five out of these six mice showed progressive growth of the tumor, while 18 mice of the same strain injected at the same time sloughed the tumor off.
This result confirms the relative inefficacy of serum as compared with lymph node cells in conferring immunity.
The Quantitative Relationship between the Number of Cells Transferred and Immunity (a) Lymph Node Mince.--
Regional lymph nodes were minced and transferred into hosts of the same strain, from C57BR/a donors which 9 days before had received an immunizing implantation of SA1. Dosages of 1, 2, and 4 donors per host were given. Test grafts of SA1 were then injected, and the effectiveness of the immunity conferred was measured in terms of the viability of these grafts after 8 days by the regraft test. The viabilities, as shown in Table IV , indicate that a dosage of less than 3 donors per host was insufficient to confer detectable immunity. A similar estimation of the effectiveness of transferred minced node is shown in Table HI of the succeeding paper (22) , in which, as will be seen, a more sensitive test detected the immunity conferred by a dosage of 2 donors per host.
(b) With Cell Suspensions.--
Suspensions of cells were transferred to hosts of the same strain, from the regional nodes of C57BR/a and C57BL/10 donors which 9 days before had received an immuui~.ing transplantation of SA1. Two suspensions were transferred in each strain, each from the Table V , where a transfer of 2 ml. cell suspension is equivalent to a dosage of 4 donors per host. A graded series of doses of cells was injected from each pool, pairs of hosts receiving 2, 1, 0.5, and 0.25 ml. cell suspension. During the C57BL/10 transfers the cells were washed by light centrifugation in the cold and resuspended in the original volume of Ringer solution. The two pools in each strain were run-and tested together, with a common control group in which no lymph node cells were transferred. Immediately after transfer of the cells, each host received a subcutaneous transplantation of 1 X 106 ascltic cells of SA1, suspended in 0.1 ml. 8 days later the tumor growths were excised and weighed.
This test of immunity proved slightly more sensitive than the regraft test. The observed weights, shown in Table V , together with the similar results shown in Table VII of the succeeding paper (22) , show that the immunity becomes more pronounced as more cells are transferred. The minimum number of cells which produced an immunity detectable by this method was of the order of S0 X 10 e.
Failure of Lympk Nodes to Give Rise to Tumors after Transplantation
Lymph nodes draining the area of regression of a tumor have been repeatedly implanted in mice susceptible to the tumor, in order to test for the presence of viable tumor cells. Regional nodes from C57BR/a mice bearing SA1 were transferred as mince into A hosts, and also from C57BL/10 mice bearing 6C3HED into C3H hosts, at 3, 5, 10, 15, and 20 days after tumor transplantation. The transferred nodes never gave rise to tumors, in agreement with the results of similar transfers reported in an earlier paper (4) . Unfortunately the possibility of antigen transfer is not eliminated by this experiment, since examples are known of tumor cells retaining their power to immunize while no longer capable of progressive growth (23, 24).
Metastases of SA1 or 6C3HED into lymph nodes have not been found during the growth of these tumors in foreign strains, except in the exceptional cases noted by Kaliss, Borges, and Day (25) , during the growth of SA1 after pretreatment of the host with lyophilized tissue.
Failure of Tumor Cells Transplanted into the Peritoneum to Affect a Simultaneous Subcutaneous Graft
Viable SA1 tissue was minced and transplanted by the same procedure as used for lymph nodes into the peritoneum of CS7BR/a hosts, each mouse receiving approximately 0.1 ml. tissue. Test grafts of SA1 were then immediately transplanted into the flank. 6C3HED was transplanted by the same procedure into CS7BL/10 hosts. In neither case did the proportion of test grafts viable after 8 days, as judged by retransfer into the susceptible strain, differ significantly from the proportion in control groups which had not been transplanted with tumor in the peritoneum. Thus lymph node cells must transfer an immunity which is effective earlier than the active immunity induced by tumor cells.
Loss of Power of Lymph Node Cells to Confer Immunity after Freezing
Lymph nodes from C$TBL/10 donors irrlmllnlzed with 6C3HED were frozen at --20°C. for a few minutes and then transferred as mince at a dosage of 4 donors per host. This treat° ment abolished the power of the cells to confer immunity. The power of larger doses of frozen cells to transfer immunity was tested with the lymph nodes of A mice injected with $778. Regional and contralateral nodes were taken 9 days after implantation of the tumor. The nodes were transferred as mince into hosts of the same strain, or were rapidly frozen in a tube immersed in an alcohol-solid COl bath (-00°C.), thawed, homogenized in a rotating blade blender~ and transplanted into the peritoneum of hosts of the A strain. In order to test for transferred immunity, a suspension of $778 cells were injected subcutaneously, and the resulting tumors weighed after 8 days. These weights are shown in Table VI. The untreated regional nodes conferred immunity, as was expected. But when transferred in large quantities after freezing, these nodes conferred no immunity and even appeared to enhance the growth of the tumor. Enhanced growth was also found in the group which received frozen contralateral nodes, and was no doubt due to serum antibody transferred with the nodes; injection of serum from immune mice has already been shown to enhance the growth of SA1.
Transfer of Cells from Donors Immunized against an Isoantigen, into //osts Carrying That Isoantigen
The design of this experiment is shown in Fig. 2 , in which four strains, and their genes at the histocompatibility-2 locus, are shown diagrammatically. At least two pairs of strains are required, each pair isogenic except at the 11-2 locus, and with no strain susceptible to the tumors of any of the other. A tumor from the strain of genetic constitution//-2" was implanted in the//-2 b strain, the two strains being isogenic except at t h e / / -2 locus. The regional lymph nodes of the recipient then produced antibody against the//-2 ~ antigen alone. They were transferred into another pair of strains isogenic except at t h e / / -2 locus, of genetic constitutions 1t-2 ~ a n d / / -2 ~. Each host was then implanted with test grafts of the tumor. Neither was susceptible, for although one of the hosts shared the//-2" antigen in common with the tumor, it differed from the tumor at other histocompatibility loci. In the case of the tt-2 ~ hosts, the transferred nodes were expected to confer heightened resistance to the tumor, and this group therefore constituted a control for the activity of the transferred lymph node cells. In the case of the//-2 ~ hosts receiving lymph node cells, the expectation depended on the hypothesis adopted for the function of the transferred cells. If an antibody-producing mechanism was transferred, t h e / / -2 " antigen in the tissues of the host should have absorbed the antibody produced by the transferred ceils before it could reach the test grafts: heightened resistance to the tumor would then not be expected. If antigen was transferred, the simplest expectation would be that all the antigens of the tumor were transferred. Then, although the H-2 ~ antigen could not have immunized the host, other antigens which could do so would be transferred: heightened resistance would be expected. However "sorted out" in this way in the donors, H-2 a antigen alone would be transferred, and heightened resistance would not be expected.
Two series of experiments were can-ied out, as shown in Table VII . In one series B10.D2 donors, corresponding to the H-g b donor strain in Fig. 2 , were transplanted by trocar with C1498. 9 days later their regional lymph nodes were transferred as mince, into the strains shown, at a dosage of 4 donors per host. These hosts, together with an untreated control group from each strain, were then implanted by trocar with test grafts of C1498. 8 days later the test grafts were pall~ted, and the fractions which were positive to palpation are shown in the table. Simple palpation, without regrafting to test viability, gave adequate discrimination between successful and unsuccessful transfer of immunity in this experiment. Each column in Table VII represents groups of mice tested at the same time, and with nodes transferred from a common group of donors. The B10.D2 group which received lymph node cells, by comparison with their control group which did not receive cells, showed that in both runs the transferred cells possessed the power to confer immunity. The LP group, with its control which did not receive cells, was the experimental group which carried the H-2 b antigen in its tissues, this antigen being the antigen against which the donors had been
TABLE VII
Success of Transfer of Immunity belween Donors and Hosts of Different Strains (a) Tr~r~fer of lymph Nods Cells from BIO.Dg (H-~) Donors Transplanle8 wilk C1498 (H-2 b)
Host strain immunized. The transferred cells had no effect in this group. The LP.RIII group, which were isogenic with LP, constituted a control in which the transferred cells did confer immunity. The histocompatibllity group of LP-RM has not been established, but it has been shown to differ from LP at the tt-2 locus. The F1 group possessed the H-2 b gene in single dosage, and this was sufficient to prevent transfer of immunity.
B10.D2 (H-2~
In the second series, C57BL/10 cells were transferred from donors injected with Bll. The C57BL/IO group showed that the cells possessed the power to confer immunity. B10.LP is isogenic with C57BL/10 except at some unestablished locus other than H-2; it is not H-2 ~ rM'acUNOLOGICAL RESPONSE TO TUMOR TRANSPLANTS. I and accordingly the B10.LP hosts showed immunity. The H-2 = antigen of strain A produces the H-2 ~ antigen; H-2 ~ was the antigen against which the donors had been immunized, and the transferred cells accordingly had no effect in this group. The A.SW group, isogenic with A except at the H-2 locus, constituted a control in which immunity was conferred. Similarly DBA/2 is H-g ~, and the cells had no effect in this group. The D2.W group, isogenic with DBA/2, was the control in which immunity was conferred.
These results are in accord with the hypothesis that lymph node cells conferred immunity by transferring an antibody-producing mechanism, and that the antibody could be absorbed by the tissues of the host. Alternately, the immunity may have been induced by transferred antigen. If this is the case, the antigens must have been sorted in the donor, so that only those were transferred which could immunize the donor.
The Duration of Transferred Immunity
The report in an earlier paper (4) that transferred immunity is of short duration, has not been confirmed by BiUingham, Brent, and Medawar (6) . The duration is important in deciding whether antigen is transferred, and has accordingly been reinvestigated.
The aim of the experiment was to compare the duration of three types of immunity; immunity actively induced by tumor grafts, ~mmunity transferred by lymph node cells from donors into hosts of the same inbred strain, and immunity transferred by lymph node cells into foreign hosts.
Certain diificulties beset any attempt to measure the duration of immunity transferred into a foreign strain, and a suitable combination of donor and host differing at the H-2 locus has not been found. An example of one obstacle is provided by the immunity against C1498 transferred by B10.D2 cells into LP.RIII hosts, in the previous experiment. Cells from donors immunized with the tumor conferred adoptive immunity; but cells from untreated B10.D2 donors could confer active immunity. C57BL/10, the strain of origin of C1498, and B10.D2 are isogenic, so they must share several antigens in common which are absent in LP.RIII mice: these antigens presumably induced the active immunity. Since transferred immunity was rapidly superseded by active immunity, its durations could not be measured. Another obstacle has already been found: the previous experiment showed that cells do not transfer immunity if an antigen of the tumor which the donor lacks is also present in the host.
For the reasons just given four pairs of strains which had slight histocompatibility differences were selected as donors and foreign hosts of transferred lymph node cells: BALB/ C -* C.B6, C57BL/10 --~ C57L, B10.D2 ~ C57BL/lO-H-2 a, and C57BL/10-H-2 ~ --* B10.D2. Each of these pairs differed at one or more histocompatibility loci, but not at the H-Z locus. Donors from each strain were injected with SA1 by trocar. 9 days later the regional lymph nodes were transferred as mince out of each donor strain into an equal number of hosts of the same strain and of the paired foreign strain, at a dosage of 4 donors per host. Groups of mice of the donor strains, transplanted at the same time as they were retained as actively immunized controls. The immunity was tested at intervals, by injectingsubcutaneously 1 X 10 e ascitic cellsof SA1 suspendedin0.1 ml., and weighing the resulting tumor growth after 8 days.
In each series tests were made together of equal numbers of mice: from the group with active immunity; from the group of the donor strain with tranderred immunity; from the group of the foreign strain with transferred immunity; and from untreated control mice of the donor and foreign strains. The mean and standard deviation of the test tumor weights from each untreated control group were calculated. A difference of more than twice the standard deviation (i.e. significant at the 5 per cent level) between this mean and the weight of a test tumor in the experimental groups was taken as evidence of immunization. 
I
The proportions of immunized mice in the tested groups are shown in Table  VIII . The numbers in each group are small, but the weights of the control tumors were sufficiently regular to give significant evidence of immunization. The data for the series with B10.D2 donors are also shown graphically in Fig. 3 .
The active immunity appeared to last over the full period of test in each series, except for one BALB/C mouse tested at 45 days. A slight but reguarl progressive increase in the test tumor weights was noted in all the actively immunized series, indicating a progressive decrease of immunity. The rate of decrease varied among strains, being most rapid for BALB/C.
In the series with C57BL/10 donors, immunity resulting from transfer of cells within the strain began to decline after 15 to 30 days, and from transfer into the foreign strain after 5 to 15 days. With BI0.D2 donors, dec!ine after transfer ~ratio~ of immunity ia d6ys
Fro. 3. The duration of immunity: (1) conferred by lymph node cells from BI0.D2 donors transplanted into B10.D2 hosts (2) conferred by lymph node cells from B10.D2 donors transplanted into C57BL/l~H-2 ' hosts (3) active immunity in B10.D2 mice.
Each point represents the ratio, of the weight attained by a single test graft of SA1, to the mean weight of control grafts of the tumor in untreated mice; the lines run through the mean ratios.
began within the strain after 7 to 10 days, and in the foreign strain after 3 to 5 days. With C57BL/10-H-2 ~ donors, in the same strain no decline was apparent over 0 to 10 days, while in the foreign strain a decline was evident over this interval. With B A L B / C donors, the decline within the strain began rapidly, after 5 to 10 days, and even appeared to begin earlier than in the foreign strain, a result which can be attributed to errors of sampling.
Immunity transferred within a strain was thus of long duration, particularly with the C57BL/10 strain. It was not perceptibly weaker in the beginning than active immunity, though presumably weaker actually; later it weakened faster than active immunity. In three of the four series, the immunity transferred into foreign hosts weakened sooner than the immunity transferred within the strain. In the foreign hosts the duration varied with the combination of donor and host, none of the durations being outside the range of survival times of homografts. The immunity still evident 15 days after C57BL/10 --~ C57L and BALB/C ~ C.B6 transfers was not unduly prolonged in view of the slight histocompatibility differences between donor and host.
Following transfer of immunity by lymph node cells a proportion of hosts still showed immunity after many weeks. At least in the cases of transfer into foreign strains, notably the two C.B6 hosts still immunized 45 days after receiving BALB/C nodes, this immunity must have been induced by antigen transferred with the cells.
DISCUSSION
Cells from the lymph nodes of immunized mice may have conferred transplantation immunity in several ways. The simplest explanation would be that tumor cells passed from the tumor into the lymph nodes of the donors, were transferred along with the lymph node cells, and induced active immunity in the host. This cannot have been the case in the present series of experiments; for the lymph nodes transplanted into mice susceptible to the tumors did not give rise to tumors, nor was active immunity induced by tumor cells effective as early as immunity conferred by lymph node cells.
The immunity could hardly have been conferred by preformed antibody carried by the cells and released into the serum of the host. If such preformed antibody was effective in combating grafts of tumor, it should have been detectable in the blood of the donors; yet whole blood and serum failed to transfer immunity. Furthermore the half-life of serum antibody was too short to account for the prolonged immunity conferred in some instances by transplanted cells.
The lymph node cells may have been immunologically activated before transfer, and could have conferred immunity by continuing to function in their host. This hypothesis is fully supported by the present observations. Immunity conferred in this way would be expected to develop earlier than active immunity, and to be lost if the cells were damaged by freezing. If the cells produced their effect through cell-bound antibody or ~/a antibody manufactured and released into the serum, an appropriate antigen in the host tissue would have blocked the effect. Transferred cells would be broken down by the homograft reaction of their host: this would account for the brief duration of immunity transferred into a foreign host. It would also account for the observation reported in the succeeding paper (22) , that hemagglutinin production terminated
earlier after transfer of lymph node ceils into a foreign host than into a host of their strain of origin. Another observation reported there also supports the hypothesis that the transferred cells function autonomously: lymph node ceils from immunized and possibly also from normal donors conferred protection against tumor homografts on "pretreated mice," i.e. mice whose own ability to resist homografts had been blocked by pretreatment with frozen or lyophilized tissue. Material may also have passed from the transplanted lymph node cells into the cells of the host and activated them immunologically. The material which was passed over, or "transduced," can be thought of either as transformed antigen or as an enzyme system for the manufacture of antibody; a logical distinction between the two can hardly be drawn. Antigen from the graft presumably enters the ceils of the draining lymph nodes and elicits the production of antibody in them, so that the presence of such a system in these cells is likely. If this hypotheses were adopted, the present work would show that the transduced material induced immunity more rapidly than normal antigen, and that it could be inactivated by freezing. It would also show that only those tumor antigens which could immunize their host are converted into transducible material. These properties are plausible, but greater difficulty is presented by the additional evidence. The transduced material must have been eliminated more rapidly in foreign hosts, and could induce immunity in "pretreated" mice, whose own ability to resist homografts had been blocked. These two pieces of evidence, however, present less difficulty than might appear. A precedent can be found for a transduced enzyme system which retains the antigenic specificity of the donor and can be destroyed by the homograft reaction while in the cells of the host: the melanin production system in the guinea pig epidermis has been shown by Billingham and Medawar (26) to behave in this way. Treatment with lyophilized tissue is not effective in a previously immunized animal (20), so that the block in the immunological response must be in the setting up and not in the working of the antibody-producing mechanism. Consequently an antibody-producing mechanism introduced into pretreated ceils might not be blocked.
Some of the present observations are analogous to observations already made in other systems of transfer of immunity by ceils.
The rapid onset of antibody production or sensitivity after cell transfer has been shown in the systems of Chase (9), of Fagreus and Grabar (10) , and of Harris, Harris, and barber (11) . Freezing and other agents which cause cell damage inhibit transfer in these systems, as also the transfer of transplantation immunity studied by Billingham, Brent, and Medawar (6) . The transfer of lymph node ceils into pretreated mice is comparable with transfer into mice with actively acquired tolerance, accord!rig to the work of Billingham, Brent, and Medawar (27) ; and with transfer into rabbits treated with x-rays, in the work of Harris, Harris, Beale, and Smith (28) . In these cases the immunological response of the host has been paralyzed, but graft resistance or serum antibody has appeared after the transfer of cells.
In the studies of Chase, of Fagreus and Grabar, and of Harris, Harris, and Farber, cells were transferred between genetically non-uniform animals. In their donor-hosts relationship, these experiments are therefore comparable with those in the present work in which cells have been transferred from one inbred strain into another. In such cases the transferred immunity lasts only a few days. The more prolonged immunity noted after transfer within the C37BL/10 and B10.D2 lines in the present work is similar to that reported after transfers of cells within the CBA line by Billingham, Brent, and Medawar (6) .
There has been no general agreement on the function of the donated cells. Fagreus and Grabar (10) note the rapidity with which transplanted spleen tissue underwent breakdown, by a process which they interpret as a homograft reaction. They suggest that any enzyme system responsible for the production of antibody is transferred into the cells of the host. Harris, Harris, Beale, and Smith (28) note the contrast between the injurious effect of x-rays on the host and the increased effectiveness of ceils transferred into an irradiated host, suggesting that the host plays a purely passive role. In a recent discussion (9), Chase has considered the possibility of activation of the cells of the host. To explain the prolonged duration of transferred cutaneous sensitivity, when compared with the rapidity with which lymphocytes are thought to be lost, he points out that "cells may not have to survive for very long in order to initiate some
process not yet understood. " Jeter, Tremaine, and Seebohm (29) have recently reported that delayed hypersensitivity to 2,4-dinitrochlorobenzene can be transferred by cells disintegrated by sonic vibration. Facts of this nature might provide decisive evidence for activation of host cells.
SUMMARY
The transfer of transplantation immunity by lymph node cells has been the subject of investigation. Transplantable tumors have been used to provoke and to measure transplantation immunity. Cells from the lymph nodes draining a tumor homograft were transferred as mince or in suspension into the peritoneum of a secondary host to confer immunity. These cells could confer immunity while the immunizing graft was undergoing breakdown during the primary, and also during the more rapid secondary, response. Cells from other nodes and from the spleen, and also whole blood or serum failed in these experiments to transfer immunity. In one combination of tumor and host, serum from immunized donors enhanced tumor growth.
Evidence has been presented favoring the hypothesis that the lymph node cells were immunologically activated before transfer, and that they conferred immunity by continuing to function in their host. Immunization by tumor cells transferred along with the cells of the nodes could not account for the failure of lymph node transferred into susceptible animals to give rise to tumors; nor for the failure of tumor cells to give rise to immunity as rapidly as transferred lymph node cells. Freezing and thawing of the transferred ceils prevented transfer of immunity. Cells from donors immunized against an isoantigen failed to confer immunity on hosts which carried that isoantigen, offering evidence of absorption of antibody. The duration of immunity transferred within an inbred strain was shorter than actively induced immunity, but longer than could have been expected of passively transferred immunity. After transfer of cells into foreign hosts, immunity declined more rapidly, as if the transferred ceils were destroyed by the homograft reaction of the host.
The possibility that cells of the host were activated has also been discussed. A brief review showed that similar problems are raised in other systems of transfer of immunity by cells.
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